Regulation of Pharmaceuticals in the Environment: The USA

作者: Emily A. McVey

DOI: 10.1007/978-1-4614-3473-3_3

关键词:

摘要: The fate of pharmaceuticals in the environment has been studied for more than 50 years, with presence and potential effects acknowledged shortly thereafter [1–5]. It gradually become apparent that risk assessments developed usual chemical contaminants cannot be applied carte blanche to pharmaceuticals, because they are highly active specific biological systems at low levels [6–9]. Therefore, when applying assessment models environmental regulators must take into account not only complexity entity protected (the ecosystem large) but also regulated article (pharmaceuticals).

参考文章(29)
Joseph Alcamo, None, Ecosystems and human well-being: a framework for assessment Island Press. ,(2003)
E. R. Peele, F. L. Singleton, J. W. Deming, B. Cavari, R. R. Colwell, Effects of Pharmaceutical Wastes on Microbial Populations in Surface Waters at the Puerto Rico Dump Site in the Atlantic Ocean Applied and Environmental Microbiology. ,vol. 41, pp. 873- 879 ,(1981) , 10.1128/AEM.41.4.873-879.1981
Dana W. Kolpin, Edward T. Furlong, Michael T. Meyer, E. Michael Thurman, Steven D. Zaugg, Larry B. Barber, Herbert T. Buxton, Response to Comment on “Pharmaceuticals, Hormones, and Other Organic Wastewater Contaminants in U.S. Streams, 1999−2000: A National Reconnaissance” Environmental Science & Technology. ,vol. 36, pp. 1054- 1054 ,(2002) , 10.1021/ES020136S
G.H. Lu, Y. Ji, H.Z. Zhang, H. Wu, J. Qin, C. Wang, Active biomonitoring of complex pollution in Taihu Lake with Carassius auratus. Chemosphere. ,vol. 79, pp. 588- 594 ,(2010) , 10.1016/J.CHEMOSPHERE.2010.01.053
D. A. SOULIDES, L. A. PINCK, F. E. ALLISON, ANTIBIOTICS IN SOILS: V. STABILITY AND RELEASE OF SOIL-ABSORBED ANTIBIOTICS Soil Science. ,vol. 94, pp. 239- 244 ,(1962) , 10.1097/00010694-196210000-00009
Francesco Pomati, Sara Castiglioni, Ettore Zuccato, Roberto Fanelli, Davide Vigetti, Carlo Rossetti, Davide Calamari, Effects of a complex mixture of therapeutic drugs at environmental levels on human embryonic cells. Environmental Science & Technology. ,vol. 40, pp. 2442- 2447 ,(2006) , 10.1021/ES051715A
Anette Küster, Alfredo C. Alder, Beate Escher, Karen Duis, Kathrin Fenner, Jeanne Garric, Tom Hutchinson, David Lapen, Alexandre Péry, Jörg Römbke, Jason Snape, Thomas Ternes, Ed Topp, Anne Wehrhan, Thomas Knacker, Environmental risk assessment of human pharmaceuticals in the European Union: A case study with the β-blocker atenolol Integrated Environmental Assessment and Management. ,vol. 6, pp. 514- 523 ,(2007) , 10.1897/IEAM_2009-050.1